Centralised authorisation procedure 2017

Updated 13 February 2018

The Danish share of assignments in the European pharmaceutical collaboration

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2017 up to and including 4th quarter

Denmark was assigned 13 human rapporteur/co-rapporteur cases and 4 veterinary rapporteur/co-rapporteur cases, which is respectively 6 % and 9 % of all assigned central procedure cases in 2017.

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2017 up to and including 4th quarter

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2017 up to and including 3rd quarter 

Figure 2. Share of human Rap/Co-rap cases

Figure 2. Share of human Rap/Co-rap cases 

Table 1: Assigned human rapporteur/co-rapporteur cases

Number of human procedures

2016

2017

Cases with DK as Rap/Co-rap

Total amount of cases

Cases with DK as Rap/Co-rap

Total amount of cases

1st quarter

0

56

2

37

2nd quarter

3

83

6

74

3rd quarter

3

51

3

48

4th quarter

1

73

2

42

Total

7

263

13

201

Figure 3. Share of veterinary Rap/Co-rap cases

Figure 3. Share of veterinary Rap/Co-rap cases 

Table 2: Assigned veterinary rapporteur/co-rapporteur cases

Number of veterinary procedures

2016

2017

Cases with DK as Rap/Co-rap

Total amount of cases

Cases with DK as Rap/Co-rap

Total amount of cases

1st quarter

2

22

1

19

2nd quarter

2

23

1

14

3rd quarter

2

16

1

7

4th quarter

0

4

1

4

Total

6

65

4

44

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.